[55 Pages Pages] The market size for synthetic stem cells is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period. The study involved four major activities in estimating the current market size for synthetic stem cells. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down approach was employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the size of the segments and subsegments of the market.
In the secondary research process, various secondary sources such as Hoovers, Bloomberg BusinessWeek, Forbes, and Dun & Bradstreet were referred to, to identify and collect information useful for this technical, market-oriented, and commercial study of the synthetic stem cells industry. These secondary sources included annual reports, press releases & investor presentations of companies; white papers; certified publications; articles by recognized authors; gold standard & silver standard websites; food safety organizations; regulatory bodies; trade directories; and databases. Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, market classification, and segmentation, according to the industry trends to the bottom-most level and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the synthetic stem cells market. The primary sources from the demand side include scientists/researchers from academic & research institutes and government & private laboratories.
After the market engineering process was completed (which includes calculations for market statistics, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the market segmentation; and key market dynamics such as drivers, restraints, opportunities, challenges, and industry trends. Given below is the breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
The top-down approach was used to estimate and validate the total size of the synthetic stem cells market. The approach was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
After arriving at the overall market size from the market size estimation process explained above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedure was employed, wherever applicable. Data was triangulated by studying various factors and trends from industry experts.
Market size available for years
Base year considered
Value (USD Million)
Application and Region
North America, Europe, APAC, and RoW
North Carolina State University (US) and Zhengzhou University (China)
This research report categorizes the synthetic stem cells market based on application and region.
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
The following customization options are available for the report:
The market size for synthetic stem cells is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period. The ethical concerns on the use of embryonic stem cells and the risk of tumor formation and immune response to natural stem cells are the key factors driving the growth of this market.
The major applications of synthetic stem cells include cardiovascular diseases, neurological disorders, and other diseases that require regenerative therapy. Cardiovascular diseases have high prevalence across the globe. Currently, synthetic mesenchymal cells have been developed only for cardiac tissue and have been tested in mice models. The research on cardiac synthetic stem cells is expected to enter the clinical phase in the coming 2-3 years, and the first commercial product would be cardiac synthetic stem cells in the next five years.
North America is estimated to account for the largest share of the market in 2023. This is majorly attributed to the rising research on stem cells in the region, coupled with public-private funding. The region is a global leader in the research on regenerative therapies such as stem cells and is backed by funding on advanced research infrastructure to commercialize novel regenerative therapies. Moreover, North America is the pioneer of synthetic stem cell technology and will be the early adopter of this technology in the coming years.
The technology is developed and patented by North Carolina State University (NCSU) (US) and Zhengzhou University (China).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Scope
2 Research Methodology
2.1 Research Design
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
5.2.1 Market Drivers
220.127.116.11 Ethical Concerns Regarding Embryonic Stem Cells
18.104.22.168 Risk of Tumor Formation and Immune Rejection of Natural Stem Cells
5.2.2 Market Restraints
22.214.171.124 Unclear and Unstructured Regulations
5.2.3 Market Opportunities
126.96.36.199 Costly Storage and Fragility of Natural Stem Cells
188.8.131.52 Potential Application in Major Indications
184.108.40.206 Increasing Stem Cell Research Funding
5.3 Market Impact Analysis
6 Synthetic Stem Cells Market, By Application
6.2 Cardiovascular Diseases
6.3 Neurological Disorders
6.4 Other Applications
7 Synthetic Stem Cells Market, By Region
7.2 North America
7.4 Asia Pacific
7.5 Rest of the World (RoW)
8 University Profiles
8.1 North Carolina State University
8.2 Zhengzhou University
9.1 Insights of Industry Experts
9.2 Discussion Guide
9.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
9.4 Introducing RT: Real-Time Market Intelligence
List of Tables (4 Tables)
Table 1 Applications: Clinical Trials
Table 2 Synthetic Stem Cells Market, By Application, 2023–2028 (USD Million)
Table 3 Synthetic Stem Cells Market, By Region, 2023–2028 (USD Million)
Table 4 North America: Synthetic Stem Cells Market, By Country, 2023–2028 (USD Million)
List of Figures (17 Figures)
Figure 1 Research Design
Figure 2 Key Data From Primary Sources
Figure 3 Breakdown of Primaries
Figure 4 Market Size Estimation
Figure 5 Market Breakdown and Data Triangulation
Figure 6 Synthetic Stem Cells Market, By Application (2023)
Figure 7 Geographical Snapshot of the Synthetic Stem Cells Market (2023)
Figure 8 Ethical Concerns, Risks Associated With Natural Stem Cells to Drive Market Growth During the Forecast Period
Figure 9 Cardiovascular Disease Segment to Account for the Largest Share in the Synthetic Stem Cells Market
Figure 10 North America to Grow at the Highest Rate During the Forecast Period
Figure 11 Stem Cell Research Funding (USD Million)
Figure 12 Stem Cell Clinical Trials
Figure 13 Cardiovascular Disease: Clinical Trials
Figure 14 Neurological Disorders: Clinical Trials
Figure 15 Other Applications: Clinical Trials
Figure 16 Geographic Snapshot: North American Synthetic Stem Cells Market
Figure 17 European Countries: Stem Cell Clinical Trials